DUBLIN, Ireland, Sept. 12, 2012 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that Roger Boissonneault, President and Chief Executive Officer, and Paul Herendeen, Executive Vice President and Chief Financial Officer, are scheduled to present at the 2012 UBS Global Life Sciences Conference on Wednesday, September 19 th at 10:00 a.m. EDT.
The CompanyWarner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, urology and dermatology segments of the pharmaceutical markets, primarily in North America. The Company is fully integrated with internal resources dedicated to the development, manufacturing and promotion of its products. WCRX-G
CONTACT: Emily Hill Investor Relations 973-907-7084 Emily.Hill@wcrx.com
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts